Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Rhythm Pharmaceuticals (RYTM) Tax Provisions: 2023-2024

Historic Tax Provisions for Rhythm Pharmaceuticals (RYTM) over the last 2 years, with Dec 2024 value amounting to $346,000.

  • Rhythm Pharmaceuticals' Tax Provisions rose 132.27% to $111,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $438,000, marking a year-over-year decrease of 32.82%. This contributed to the annual value of $346,000 for FY2024, which is 38.65% down from last year.
  • Per Rhythm Pharmaceuticals' latest filing, its Tax Provisions stood at $346,000 for FY2024, which was down 38.65% from $564,000 recorded in FY2023.
  • Rhythm Pharmaceuticals' Tax Provisions' 5-year high stood at $564,000 during FY2023, with a 5-year trough of $346,000 in FY2024.
  • Over the past 2 years, Rhythm Pharmaceuticals' median Tax Provisions value was $455,000 (recorded in 2023), while the average stood at $455,000.
  • Data for Rhythm Pharmaceuticals' Tax Provisions shows a maximum YoY plummeted of 38.65% (in 2024) over the last 5 years.
  • Over the past 2 years, Rhythm Pharmaceuticals' Tax Provisions (Yearly) stood at $564,000 in 2023, then tumbled by 38.65% to $346,000 in 2024.